keyword
https://read.qxmd.com/read/36941611/isoginkgetin-loaded-reactive-oxygen-species-scavenging-nanoparticles-ameliorate-intervertebral-disc-degeneration-via-enhancing-autophagy-in-nucleus-pulposus-cells
#21
JOURNAL ARTICLE
Hao Yu, Yun Teng, Jun Ge, Ming Yang, Haifeng Xie, Tianyi Wu, Qi Yan, Mengting Jia, Qing Zhu, Yanping Shen, Lianxue Zhang, Jun Zou
Excessive reactive oxygen species (ROS) in nucleus pulposus cells (NPCs) promote extracellular matrix (ECM) degradation and cellular inflammatory responses by activating a variety of cellular pathways, ultimately inducing cell apoptosis and leading to the development of low back pain. Here, we designed and fabricated an isoginkgetin-loaded ROS-responsive delivery system (IGK@SeNP) based on diselenide block copolymers. Successfully encapsulated IGK was released intelligently and rapidly in a microenvironment with high ROS levels in degenerative disc...
March 21, 2023: Journal of Nanobiotechnology
https://read.qxmd.com/read/36895760/a-recombinant-9e1-monoclonal-antibody-binds-membrane-and-soluble-channel-catfish-immunoglobulin-m
#22
JOURNAL ARTICLE
Miles D Lange, Emily M Churchman, Allison L Wise, Timothy J Bruce
The development and validation of the recombinant 9E1 monoclonal antibody against channel catfish IgM is described. The variable heavy and light chain domains of the 9E1 hybridoma were cloned into murine IgG1 and IgK expression vectors. These expression plasmids were co-transfected into 293F cells and mature IgG was purified from culture supernatant. It is demonstrated that the recombinant 9E1 monoclonal antibody binds to soluble IgM in ELISA and ELISPOT assays and to membrane-bound IgM by immunofluorescence with different B-cell types...
December 2023: Fish Shellfish Immunol Rep
https://read.qxmd.com/read/36867981/exploring-the-sheep-ovis-aries-immunoglobulin-repertoire-by-next-generation-sequencing
#23
JOURNAL ARTICLE
Minyoung Park, Teresa Nunez de Villavicencio Diaz, Victoria Lange, Lin Wu, Thierry Le Bihan, Bin Ma
Next-generation sequencing (NGS) has revolutionized the way we determine the antibody repertoires encoded by B cells in the blood or lymphoid organs and transformed our understanding of adaptive immune responses in many species. Sheep (Ovis aries) have been widely used as a host for therapeutic antibody production since the early 1980s, however, little is known about their immune repertoires or immunological processes affecting the antibody generation. The objective of this study was to employ NGS for a comprehensive analysis of immunoglobulin heavy and light chain repertoires in four healthy sheep...
March 1, 2023: Molecular Immunology
https://read.qxmd.com/read/36867579/diagnostic-utility-of-whole-genome-sequencing-in-adults-with-b-other-acute-lymphoblastic-leukemia
#24
JOURNAL ARTICLE
Daniel Leongamornlert, Jesús Gutiérrez-Abril, Soo Wah Lee, Emilio Barretta, Tom Creasey, Gunes Gundem, Max Fine Levine, Juan Esteban Arango Ossa, Konstantinos Liosis, Juan Santiago Medina-Martinez, Krisztina Zuborne Alapi, Amy A Kirkwood, Laura Clifton-Hadley, Pip Patrick, David Jones, Laura J O'Neill, Adam P Butler, Christine J Harrison, Peter J Campbell, Bela Patel, Anthony V Moorman, Adele K Fielding, Elli Papaemmanuil
Genomic profiling at diagnosis of B-cell precursor Acute Lymphoblastic Leukemia (BCP-ALL) in adults is used to guide disease classification, risk stratification and treatment decisions. Patients for which diagnostic screening fails to identify disease defining or risk stratifying lesions are classified as B-other ALL. We screened a cohort of 652 BCP-ALL cases enrolled in UKALL14 to identify and perform whole genome sequencing (WGS) on paired tumor-normal samples. For 52 B-other patients we compared WGS findings to data from clinical and research cytogenetics...
March 3, 2023: Blood Advances
https://read.qxmd.com/read/36755997/uncommon-presentation-of-undiagnosed-b-cell-lymphoproliferative-disorder-as-nodular-pulmonary-amyloidosis
#25
Harsh Patel, Aaiyat Sheikh, Gnana Deepthi Medarametla, Sri Abirami Selvam, Syed Nazeer Mahmood, Gurleen Johal, Janani Arunachalam, Haripriya Radhakrishnan, Viray Shah, Aditya Lal Vallath, Digantkumar Patel, Saketh Palasamudram Shekar, Urvish Patel, Nisarg Changawala
B-cell lymphoproliferative disorders are characterized by the accumulation of mature B lymphocytes in the bone marrow, lymphoid tissues, and/or peripheral blood. They can cause amyloid deposits in the lungs. In rare cases, lung nodules can be the first sign of this disorder. We present the case of an 89-year-old woman with stable shortness of breath and lung nodules on imaging. A positron emission tomography-computed tomography (PET-CT) scan showed the most intense hypermetabolic nodule in the patient's lung, which was 1...
January 2023: Journal of Medical Cases
https://read.qxmd.com/read/36717722/enhancer-instructed-epigenetic-landscape-and-chromatin-compartmentalization-dictate-a-primary-antibody-repertoire-protective-against-specific-bacterial-pathogens
#26
JOURNAL ARTICLE
E Mauricio Barajas-Mora, Lindsay Lee, Hanbin Lu, J Andrés Valderrama, Elisabet Bjanes, Victor Nizet, Ann J Feeney, Ming Hu, Cornelis Murre
Antigen receptor loci are organized into variable (V), diversity (D) and joining (J) gene segments that rearrange to generate antigen receptor repertoires. Here, we identified an enhancer (E34) in the murine immunoglobulin kappa (Igk) locus that instructed rearrangement of Vκ genes located in a sub-topologically associating domain, including a Vκ gene encoding for antibodies targeting bacterial phosphorylcholine. We show that E34 instructs the nuclear repositioning of the E34 sub-topologically associating domain from a recombination-repressive compartment to a recombination-permissive compartment that is marked by equivalent activating histone modifications...
February 2023: Nature Immunology
https://read.qxmd.com/read/36684058/primary-nodal-unclassifiable-cd20-negative-diffuse-large-b-cell-lymphoma-with-dual-igk-and-tcr-gene-rearrangement-a-diagnostic-challenge
#27
Ita Hadžisejdić, Lucia Klarica, Emina Babarović, Blažen Marijić, Toni Valković, Nives Jonjić
Non-Hodgkin lymphomas are most frequently classified based on the lineage marker expression. However, lymphomas with aberrant marker expression as well as monoclonal IgH/Ig Κ and TCR gene rearrangements may co-exist which can be misleading and confusing. Primary CD20 negative diffuse large B-cell lymphomas (DLBCL) represent a rare entity, and they account for 1% to 3% of cases. However, some CD20 negative DLBCLs could not be classified into known variants, creating both diagnostic and therapeutic dilemma's...
2023: Clinical pathology
https://read.qxmd.com/read/36428786/plasticity-in-classical-hodgkin-composite-lymphomas-a-systematic-review
#28
REVIEW
Alexis Trecourt, Marie Donzel, Juliette Fontaine, Hervé Ghesquières, Laurent Jallade, Gabriel Antherieu, Camille Laurent, Claire Mauduit, Alexsandra Traverse-Glehen
The co-occurrence of several lymphomas in a patient defines composite/synchronous lymphoma. A common cellular origin has been reported for both contingents of such entities. In the present review, we aimed to gather the available data on composite lymphomas associating a classical Hodgkin lymphoma (cHL) with another lymphoma, to better understand the plasticity of mature B and T-cells. This review highlights that >70% of patients with a composite lymphoma are ≥55 years old, with a male predominance...
November 19, 2022: Cancers
https://read.qxmd.com/read/36333348/identification-of-potential-blood-biomarkers-for-early-diagnosis-of-alzheimer-s-disease-through-immune-landscape-analysis
#29
JOURNAL ARTICLE
Daichi Shigemizu, Shintaro Akiyama, Risa Mitsumori, Shumpei Niida, Kouichi Ozaki
Mild cognitive impairment (MCI) is a clinical precursor of Alzheimer's disease (AD). Recent genetic studies have reported on associations between AD risk genes and immunity. Here, we obtained samples and data from 317 AD, 432 MCI, and 107 cognitively normal (CN) subjects and investigated immune-cell type composition and immune clonal diversity of T-cell receptor (TRA, TRB, TRG, and TRD) and B-cell receptor (IGH, IGK, and IGL) repertoires through bulk RNA sequencing. We found the proportions of plasma cells, γδ T cells, neutrophils, and B cells were significantly different and the diversities of IGH, IGK, and TRA were significantly small with AD progression...
November 4, 2022: NPJ Aging
https://read.qxmd.com/read/36252861/role-of-immunoglobulin-heavy-and-light-chain-gene-rearrangement-analysis-in-differentiating-between-benign-and-malignant-bone-marrow-b-cell-lymphoid-aggregates
#30
JOURNAL ARTICLE
Mark G Evans, Russell K Brynes, Anthony Crymes, Jack Reid, Nahideh Haghighi, Christopher Botros, Xiaohui Zhao, Sherif A Rezk
Lymphoid aggregates are found in a minority of bone marrow biopsy and aspirate specimens, and when present, the distinction between benign and malignant aggregates can represent a diagnostic challenge. Morphologic and immunophenotypic evaluation of the aggregates can aid in that distinction but in a few cases, detection of immunoglobulin heavy chain (IGH) and kappa light chain (IGK) gene rearrangements may be needed to rule in or out a malignant disease process. We studied the role of testing for IGH/IGK rearrangements in the distinction between benign and malignant B cell-predominant lymphoid aggregates...
October 15, 2022: Human Pathology
https://read.qxmd.com/read/36191469/a-clonality-assay-in-canine-b-cell-tumors-targeting-the-immunoglobulin-light-chain-lambda-locus
#31
JOURNAL ARTICLE
Masamine Takanosu, Yumiko Kagawa
Clonality assays for antigen receptor rearrangement have been used as adjunct examinations of lymphoproliferative diseases. These assays have been useful for differentiation between inflammation and clonal expansion of lymphocytes. Whereas the immunoglobulin heavy chain (IGH) and immunoglobulin light chain kappa (IGK) loci have been targeted in canine clonality assays previously, the immunoglobulin light chain lambda gene (IGL) locus has not yet been investigated. This study aimed to evaluate the usefulness of clonality assays in dogs using IGL...
September 28, 2022: Veterinary Immunology and Immunopathology
https://read.qxmd.com/read/36185293/clinical-implication-of-minimal-residual-disease-assessment-by-next-generation-sequencing-based-immunoglobulin-clonality-assay-in-pediatric-b-acute-lymphoblastic-leukemia
#32
JOURNAL ARTICLE
Jae Wook Lee, Yonggoo Kim, Ari Ahn, Jong Mi Lee, Jae Won Yoo, Seongkoo Kim, Bin Cho, Nack-Gyun Chung, Myungshin Kim
Measuring minimal residual disease (MRD) during treatment is valuable to identify acute lymphoblastic leukemia (ALL) patients who require intensified treatment to avert relapse. We performed the next-generation sequencing (NGS)-based immunoglobulin gene (Ig) clonality assay and evaluated its clinical implication in pediatric B-ALL patients to assess MRD. Fifty-five patients who were diagnosed and treated with de novo ( n = 44) or relapsed/refractory B-ALL ( n = 11) were enrolled. MRD assessment was performed using the LymphoTrack® Dx IGH and IGK assay panels...
2022: Frontiers in Oncology
https://read.qxmd.com/read/36162256/isoginkgetin-a-bioactive-constituent-from-ginkgo-biloba-protects-against-obesity-induced-cardiomyopathy-via-enhancing-nrf2-are-signaling
#33
JOURNAL ARTICLE
Xiaoqian Wu, Jianrong Huang, Junyuan Tang, Yuling Sun, Guojun Zhao, Cuishi Yan, Zhenghong Liu, Wei Yi, Suowen Xu, Xiyong Yu
Obesity-induced metabolic cardiomyopathy (MC), characterized by lipotoxicity and excessive oxidative stress, emerges as the leading cause of heart failure in the obese patients. Yet, its therapy remains very limited. Here, we demonstrated that isoginkgetin (IGK), a bioactive biflavonoid isolated from medicinal herb Ginkgo Biloba, protected against obesity-induced cardiac diastolic dysfunction and adverse remodeling. Transcriptomics profiling revealed that IGK activated Nrf2 signaling in the heart tissues of the obese mice...
September 20, 2022: Redox Biology
https://read.qxmd.com/read/36109452/expression-of-a-secretable-cell-penetrating-cdkl5-protein-enhances-the-efficacy-of-gene-therapy-for-cdkl5-deficiency-disorder
#34
JOURNAL ARTICLE
Giorgio Medici, Marianna Tassinari, Giuseppe Galvani, Stefano Bastianini, Laura Gennaccaro, Manuela Loi, Nicola Mottolese, Sara Alvente, Chiara Berteotti, Giulia Sagona, Leonardo Lupori, Giulia Candini, Helen Rappe Baggett, Giovanna Zoccoli, Maurizio Giustetto, Alysson Muotri, Tommaso Pizzorusso, Hiroyuki Nakai, Stefania Trazzi, Elisabetta Ciani
Although delivery of a wild-type copy of the mutated gene to cells represents the most effective approach for a monogenic disease, proof-of-concept studies highlight significant efficacy caveats for treatment of brain disorders. Herein, we develop a cross-correction-based strategy to enhance the efficiency of a gene therapy for CDKL5 deficiency disorder, a severe neurodevelopmental disorder caused by CDKL5 gene mutations. We created a gene therapy vector that produces an Igk-TATk-CDKL5 fusion protein that can be secreted via constitutive secretory pathways and, due to the cell-penetration property of the TATk peptide, internalized by cells...
September 15, 2022: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://read.qxmd.com/read/36012390/high-igkc-expressing-intratumoral-plasma-cells-predict-response-to-immune-checkpoint-blockade
#35
JOURNAL ARTICLE
Juan Luis Onieva, Qingyang Xiao, Miguel-Ángel Berciano-Guerrero, Aurora Laborda-Illanes, Carlos de Andrea, Patricia Chaves, Pilar Piñeiro, Alicia Garrido-Aranda, Elena Gallego, Belén Sojo, Laura Gálvez, Rosario Chica-Parrado, Daniel Prieto, Elisabeth Pérez-Ruiz, Angela Farngren, María José Lozano, Martina Álvarez, Pedro Jiménez, Alfonso Sánchez-Muñoz, Javier Oliver, Manuel Cobo, Emilio Alba, Isabel Barragán
Resistance to Immune Checkpoint Blockade (ICB) constitutes the current limiting factor for the optimal implementation of this novel therapy, which otherwise demonstrates durable responses with acceptable toxicity scores. This limitation is exacerbated by a lack of robust biomarkers. In this study, we have dissected the basal TME composition at the gene expression and cellular levels that predict response to Nivolumab and prognosis. BCR, TCR and HLA profiling were employed for further characterization of the molecular variables associated with response...
August 15, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/35918464/clinical-application-of-next-generation-sequencing-based-monitoring-of-minimal-residual-disease-in-childhood-acute-lymphoblastic-leukemia
#36
JOURNAL ARTICLE
Huirong Mai, Qin Li, Guobing Wang, Ying Wang, Shilin Liu, Xue Tang, Fen Chen, Guichi Zhou, Yi Liu, Tonghui Li, Lulu Wang, Chunyan Wang, Feiqiu Wen, Sixi Liu
BACKGROUND: Next-generation sequencing (NGS) is an emerging technology that can comprehensively assess the diversity of the immune system. We explored the feasibility of NGS in detecting minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) based on immunoglobulin and T cell receptor. METHODS: Bone marrow samples were collected pre- and post-treatment with pediatric ALL admitted to Shenzhen Children's Hospital from February 1st, 2020 to January 31st, 2021...
August 2, 2022: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/35896862/tumor-resident-b-cell-receptor-chemical-characteristics-associated-with-better-overall-survival-for-neuroblastoma
#37
JOURNAL ARTICLE
Dorottya B Kacsoh, Dhruv N Patel, Monica Hsiang, Etienne C Gozlan, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
Pediatric neuroblastoma (NBL) is one of the most common pediatric cancers, and it can often be aggressive. Genetic and demographic factors can correlate with the severity of NBL, but the variations in the B-cell receptors (BCRs) or immunoglobulin proteins present in the NBL tumors, and their relationships to survival, are not well understood. BCRs contain variations in their complementary determining region-3 (CDR3s) amino acid sequences, due to variable recombinations of the V- and J-gene segments. Accordingly, these variations in CDR3s may represent different antigen interactions and thereby different survival probabilities...
September 2022: Journal of Molecular Neuroscience: MN
https://read.qxmd.com/read/35836570/exploration-of-shared-gene-signatures-and-molecular-mechanisms-between-periodontitis-and-nonalcoholic-fatty-liver-disease
#38
JOURNAL ARTICLE
Wanqiu Xu, Zhengwei Zhang, Lihong Yao, Bing Xue, Hualei Xi, Xiumei Wang, Shibo Sun
Background: Periodontitis is associated with periodontal tissue damage and teeth loss. Nonalcoholic fatty liver disease (NAFLD) has an intimate relationship with periodontitis. Nevertheless, interacted mechanisms between them have not been clear. This study was intended for the exploration of shared gene signatures and latent therapeutic targets in periodontitis and NAFLD. Methods: Microarray datasets of periodontitis and NAFLD were obtained from the Gene Expression Omnibus (GEO) database. The weighted gene co-expression network analysis (WGCNA) was utilized for the acquisition of modules bound up with NAFLD and periodontitis...
2022: Frontiers in Genetics
https://read.qxmd.com/read/35802654/development-and-application-of-a-next-generation-sequencing-protocol-and-bioinformatics-pipeline-for-the-comprehensive-analysis-of-the-canine-immunoglobulin-repertoire
#39
JOURNAL ARTICLE
Jonah N Cullen, Jolyon Martin, Albert J Vilella, Amy Treeful, David Sargan, Allan Bradley, Steven G Friedenberg
Profiling the adaptive immune repertoire using next generation sequencing (NGS) has become common in human medicine, showing promise in characterizing clonal expansion of B cell clones through analysis of B cell receptors (BCRs) in patients with lymphoid malignancies. In contrast, most work evaluating BCR repertoires in dogs has employed traditional PCR-based approaches analyzing the IGH locus only. The objectives of this study were to: (1) describe a novel NGS protocol to evaluate canine BCRs; (2) develop a bioinformatics pipeline for processing canine BCR sequencing data; and (3) apply these methods to derive insights into BCR repertoires of healthy dogs and dogs undergoing treatment for B-cell lymphoma...
2022: PloS One
https://read.qxmd.com/read/35741199/lymphotrack-is-equally-sensitive-as-pcr-genescan-and-sanger-sequencing-for-detection-of-clonal-rearrangements-in-all-patients
#40
JOURNAL ARTICLE
Karin Paulsen, Millaray Marincevic, Lucia Cavelier, Peter Hollander, Rose-Marie Amini
Monoclonal rearrangements of immunoglobulin (Ig) genes and T-cell receptor (TCR) genes are used for minimal measurable disease in acute lymphoblastic leukemia (ALL). The golden standard for screening of gene rearrangements in ALL has been PCR GeneScan and Sanger sequencing, which are laborsome and time-consuming methods. More rapid next-generation sequencing methods, such as LymphoTrack could possibly replace PCR GeneScan and Sanger sequencing for clonality assessment. Our aim was to evaluate to what extent LymphoTrack can replace PCR GeneScan and Sanger sequencing concerning sensitivity and quantifiability in clonality assessment in 78 ALL samples...
June 4, 2022: Diagnostics
keyword
keyword
67623
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.